|
Re: Already posted by someone else??
|
2
|
Resverlogix Corp.
|
Sep 27, 2022 03:22PM
|
|
Tablet vs Capsule
|
2
|
Resverlogix Corp.
|
Feb 13, 2021 05:38PM
|
|
Re: Finally got around to this. UN-official, of course
|
2
|
Resverlogix Corp.
|
Sep 17, 2015 03:51PM
|
|
Crack down on Reporting failures in clinical trials .gov?
|
2
|
Resverlogix Corp.
|
May 09, 2021 02:57PM
|
|
Did anyone go to BioInvestor/hear the talk?
|
2
|
Resverlogix Corp.
|
Oct 22, 2015 12:06AM
|
|
Re: Here is the example of the danger of the COVID trial to RVX...
|
2
|
Resverlogix Corp.
|
Nov 12, 2021 11:49AM
|
|
Zenith Epigenetics 150513 Conf Call
|
2
|
Resverlogix Corp.
|
May 20, 2015 02:18PM
|
|
Re: Drug Discovery Targeting BRD4
|
2
|
Resverlogix Corp.
|
Oct 04, 2017 02:36PM
|
|
Ironic but possible opportunity?
|
2
|
Resverlogix Corp.
|
Sep 17, 2015 05:04PM
|
|
Re: RVX AGM 171212 - Rough Transcription - Not proofed or edited. Feel free to correct.
|
2
|
Resverlogix Corp.
|
Dec 15, 2017 12:07AM
|
|
Re: Apabetalone recudes ALP (apologies if repeat. looked on the new side)
|
2
|
Resverlogix Corp.
|
Jun 11, 2020 12:54AM
|
|
Re: RVX AGM 171212 - Rough Transcription - Not proofed or edited. Feel free to correct.
|
2
|
Resverlogix Corp.
|
Dec 15, 2017 12:11AM
|
|
COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
|
2
|
Resverlogix Corp.
|
Nov 10, 2021 10:44AM
|
|
COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
|
2
|
Resverlogix Corp.
|
Nov 10, 2021 10:45AM
|
|
COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
|
2
|
Resverlogix Corp.
|
Nov 10, 2021 10:49AM
|
|
Re: Compilation of BET inhibitor Trials
|
2
|
Resverlogix Corp.
|
Oct 05, 2017 09:08PM
|
|
Re: Downloaded presentation…
|
2
|
Resverlogix Corp.
|
Jun 22, 2021 03:41PM
|
|
Re: 60/160 Treatments in Development for CoronaVirus - Did not see Apabetalone in Quick Scan
|
2
|
Resverlogix Corp.
|
Apr 25, 2020 12:15AM
|
|
Regarding that UCSF study identifying 69 targets - someone made this comment
|
2
|
Resverlogix Corp.
|
Apr 03, 2020 11:24PM
|
|
Re: BETonMACE Prespecified Cognition Assessment Results - Post-CTAD Conference Call - Transcript - 191206
|
2
|
Resverlogix Corp.
|
Dec 09, 2019 12:09AM
|
